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• People with dementia living in RACFs are largely inactive and often have sleep 
disturbances. 
• A non-facilitated individual PARO intervention had some effect on sleep duration. 
• There was no evidence that PARO had an effect on motor activity. 
• Using wearable actigraphy for research in people with dementia is challenging. 
 
Abstract 
Objective: To investigate the effect of a social robot intervention on sleep and motor activity 
in nursing home residents living with dementia and chronic pain.  
Method: A pilot randomized controlled trial was conducted with 41 residents from three 
Australian nursing homes. People living with dementia and chronic pain were randomized 
into either a 30-minute daily social robot (PARO) condition or a usual care condition during 
six weeks. Sleep and motor activity were assessed by actigraphy at four-time points: week 0 
at baseline, week one, week six, and after the intervention. Data were reduced into daytime 
(8:00am - 7:59pm) and night-time (8:00pm - 7:59am) summaries. Change scores for each 
time point compared to baseline were computed for data analysis and the generalized 
estimating equation model with imbalanced baseline values added as covariates were 
performed.  
Results: At week one, residents in the PARO group had a greater increase in the night sleep 
period (1.81, 95% CI: 0.22 to 3.84, p = 0.030, Cohen’s d = 0.570). At week six, residents in 
the PARO group showed a greater increase in daytime wakefulness (1.91, 95% CI: 0.09 to 
3.73, p = 0.042, Cohen’s d = 0.655) and a greater reduction in daytime sleep (-1.35, 95% CI: 




Conclusion: PARO could be a potentially beneficial therapy to improve sleep patterns for 
nursing home residents living with dementia and chronic pain, but the effect of PARO on 
motor activity needs further research. 
Australian New Zealand Clinical Trials Registry (ACTRN12618000082202). 




Sleep disturbances and physical inactiveness are common in people with dementia living in 
residential aged care facilities (RACFs). Up to 70% of individuals with dementia are affected 
by disturbed sleep [1] and people with dementia living in residential aged care facilities 
(RACFs) are reported to spend around 85% of their daytime physically inactive [2]. 
Disturbed sleep and decreased physical function can have significant consequences, such as 
greater risks of injuries [3] and increased caregiver burden [4]. Pain is generally linked to 
sleep disturbances [5] and may inhibit physical activity [6]. Over half the people with 
dementia living in RACFs are affected by pain [7]. Evidence suggests that appropriate pain 
management may improve sleep [8] and physical functions of residents with dementia [9].  
Despite the increasing use of pain medications, over 50% of residents living in 
RACFs are affected by clinically relevant pain that may trigger behavioral and psychological 
symptoms [10]. There is some evidence that psychosocial interventions may be effective in 
pain alleviation for people with dementia [11]. Social robots, which are defined as an 
artificial agent embodied with features of a human or an animal, has been identified as an 
approach to meet the mental health needs of older adults through interaction or information 
exchange [12]. Social robots are reported to improve the well-being of a variety of 
population, especially for older adults with dementia [13]. Sleep quality and motor activity 
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are important indicators of well-being, but until now have not been widely measured as 
effective outcomes in studies using social robots. Several studies suggest that social robot 
interventions may have the potential to positively affect sleep parameters for people with 
dementia. For example, the robotic seal PARO, has been reported to improve sleep behaviors 
for people with dementia [14]. Studies with older women showed that living with a 
communication robot tended to increase nocturnal sleep hours and decrease the difficulty in 
maintaining sleep [15]. Additionally, one study found that participants in a PARO group had 
a greater reduction in night-time motor activity than the usual-care group [16]. Although 
studies have demonstrated potential benefits of social robots for people with dementia, none 
of these studies reported its effect on people with both dementia and chronic pain from 
randomized controlled trials. While chronic pain may be a risk factor for sleep problems and 
physical functions in older persons, PARO is hypothesized to have the potential to reduce 
pain and subsquently lead to improvements in sleep and motor activity for people with 
dementia and chronic pain living in RACFs.  
2. Methods 
2.1 Design 
This study was performed as part of a pilot randomized controlled trial, exploring the 
feasibility and effect of a social robot (PARO) intervention for people with dementia and 
chronic pain living in RACFs in Australia from January 2018 to January 2019 [17]. 
Participants were randomized into either a daily (Monday to Friday) 30-minute individual, 
non-facilitated PARO condition or a usual care condition (e.g., music, bingo, activities, etc.) 
for six weeks by a computer-generated random list. Given the nature of psychosocial 
interventions, both participants and researchers were not blinded to the random allocation. 
Sample size calculation was based on the primary outcome of observational pain levels [17].   
Our previously published paper of the study primary outcomes indicated the PARO 
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intervention shows promise in reducing pain and as needed medications for individuals with 
dementia in RACFs [17]. In this paper, findings from the study’s secondary outcomes of 
sleep and motor activity are presented. Due to the lack of studies in this area, preliminary 
evidence from this pilot RCT may help determine the effect of the PARO intervention on 
sleep and motor activity in people with dementia and chronic pain living in RACFs and to 
inform the required sample size for a larger trial. 
2.2 PARO 
PARO, a therapeutic robotic seal, is a psychosocial intervention and can be described as a 
socially assistive robot to enhance communication, socialisation, and emotional connection 
for people living with dementia [18]. PARO has the appearance of a baby harp seal and is 
covered with artificial fur. It has four senses of sight, hearing, balance and tactile to respond 
and communicate with users by moving or making a sound. Interacting with PARO can make 
people feel happy and they may enjoy having PARO for a companion, which reflects the 
therapeutic effect of PARO on users [18].  
2.3 Sample 
Convenience sampling was used to recruit participants who met the following criteria:  
(1) Aged 65 years and older; (2) Participants must have been diagnosed with some form of 
dementia, or probable diagnosis of dementia; (3) Being prescribed pain medications or an 
indication of chronic pain. For those who cannot self-report pain, proxy reports of pain from 
registered nurses (RNs) for the previous week were obtained; (4) Demonstration of perceived 
senses for interaction with PARO, such as vision, hearing or touch; and (5) Living in a 
facility for more than three months. 
Participants were ineligible for participation if they met at least one of the following 
criteria: (1) Diseases such as acute exacerbation of chronic obstructive pulmonary disease or 
renal failure that required residents to be admitted to hospital frequently; (2) Terminal 
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illnesses where the resident is in the final palliative stage; (3) A diagnosis of a major mental 
illness such as schizophrenia; (4) Infectious diseases or with an open wound that was unable 
to be covered. 
2.4 Outcome measures 
Socio-demographic information of participants was assessed at baseline. Cognitive status was 
assessed using the Mini-Mental State Examination (MMSE) [19]. Medical conditions, 
dementia subtypes and medication use were audited from the residents’ medical records. 
Researchers collected proxy assessments of pain history (e.g., pain frequency, onset, 
intensity, locations, and nonpharmacological therapies) through structured interviews with 
the nursing staff who had regular contact with the resident. 
Given the challenges of measuring sleep and motor activity in people with dementia, 
the use of actigraphy was deemed to be feasible and acceptable in people with dementia [20, 
21]. It is an objective measurement of sleep patterns and motor activity while avoiding 
reliance on over- or under-estimated reports from caregiver [21, 22]. The actigraphy used in 
this study was the SenseWear Professional 8.0 activity armband (Body Media, Inc) [23]. It is 
a wireless, slim, nonintrusive armband which is placed on participants’ upper non-dominant 
upper arm over the tricep muscle and held in place by a Velcro armband. Several sensors 
related to sleep and motor activity are incorporated into this device. Data was collected over 
24 hours with participants on four occasions: (1) Sunday of week 0 before the intervention 
(baseline); (2) Monday of the first week for intervention (at week 1); (3) Friday of week six 
for intervention (at week 6); and (4) Saturday of week six (after), removing only for bathing 
or discomfort. Care workers were trained on how to put on and take off the armband. 
Instructions for administering the SenseWear were also placed in the residents’ rooms and in 
the nurses’ office to explain the use of the actigraph and objectives of the study. The 
researcher checked the skin of the resident daily to ensure that the armband did not cause a 
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tear, lesions, or rash and swelling due to allergy.  
According to a previously published study [16], data at each time point were reduced 
into daytime (8:00am - 7:59pm) and night-time (8:00pm - 7:59am) summaries.  Outcomes 
were changes in participants’ levels of sleep and motor activity at week six. Sleep patterns 
were measured by the time spent (hours) (1) lying down; (2) awake; and (3) sleep (light 
sleep, deep sleep and very deep sleep). Motor activity was measured by (1) skin temperature; 
(2) distance walked (kilometers); (3) number of steps taken; (4) time spent (hours) in at least 
light physical activity (>1.5 metabolic equivalent of task); and (5) energy expenditure (kcal). 
Short term and prolonged effects at week 1 and week 6 were also examined respectively. 
2.5 Data analysis 
All data analysis was conducted using IBM SPSS Statistics software 25.0. The last 
observation carried forward was used to manage missing data for outcomes. SenseWear data 
were extracted using SenseWear software and then uploaded to a password protected PC for 
analysis. The generalized estimating equation (GEE) model with imbalanced baseline values 
added as covariates was used to explore the effect of PARO interventions on outcomes. 
Change scores from baseline to each time point with 95% confidence intervals (CIs) between 
two groups were computed for analyses. Cohen’s d for effect size (0.20 = small effect, 0.50 = 
moderate effect, and 0.80 = large effect) [24] was calculated and statistical significance was 
set at p<0.05. 
3. Results 
Forty-three residents from three RACFs were randomly allocated to the intervention group 
(n=21) and the control group (n=22). Two residents from the control group refused to put on 
the armband, and they were excluded from the data analysis. The attrition rate of participants 
was 7.0% with three drop-outs due to death (n=2) and loss of interest (n=1). No adverse 
events (e.g., skin tear, allergy, etc.) were recorded during the data collection. Figure 1 shows 
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the CONSORT flow diagram.  
<Inert Figure 1 here> 
3.1 Demographic comparisons between the two groups 
The percentage of females is significantly higher (p=0.033) in the intervention group (85.7%) 
than in the control group (55.0%). Apart from gender, the demographics and medical 
conditions of participants in the two groups were comparatively similar before the 
intervention (Table 1).  
<Inert Table 1 here> 
3.2 Baseline outcome measures between the two groups 
Compared to residents in the control group at baseline, residents in the PARO group had 
fewer daytime step counts (p=0.039), shorter night-time awake hours (p=0.030) and less 
daytime (p=0.032) and night-time (p=0.039) energy expenditure (Table 2). 
<Inert Table 2 here> 
3.3 The effect of PARO intervention on sleep and motor activity  
The effect of the six-week PARO intervention  
At the end of the six-week PARO intervention, compared to the control condition, the 
duration of daytime wakefulness was significantly increased (1.91, 95% CI: 0.09 to 3.73, 
p=0.042, Cohen’s d=0.655) and the duration of daytime sleep was significantly decreased (-
1.35, 95% CI: -2.65 to -0.05, p=0.040, Cohen’s d=0.664) in the PARO group, especially in 
the reduction of daytime light sleep (-1.27, 95% CI: -2.36 to -0.19,  p=0.023, Cohen’s 
d=0.746) (Table 3). There were no significant differences in daytime motor activity and all 
night-time outcomes. 
Short-term effect of PARO intervention 
After one session of PARO intervention at week 1, the increase in the duration of light sleep 
at night was significantly higher in the PARO group when compared to the control group 
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(1.81, 95% CI: 0.22 to 3.84, p=0.030, Cohen’s d=0.570) (Table 3). However, no significant 
differences were found in daytime outcomes. 
Sustained effect of PARO intervention  
There were no significant differences in the change of sleep and motor activity between the 
PARO and control group after the six-week intervention (Table 3), which means that there 
was insufficient evidence to support the sustained effect of the PARO intervention on any 
outcomes.  
<Inert Table 3 here> 
3.4 The use of SenseWear armband with people with dementia  
The SenseWear armband was not well tolerated in people with dementia, with just seven 
participants having a valid wear-time of ≥10 hours for four measurements. The average 
length of wear-time was 10.16 (± 2.68) hours during day time and 9.73 (± 4.2) hours at night. 
The main reason for low compliance was that residents took off the armband due to their 
unwillingness to wear the armband, especially at night. All devices were returned intact with 
no evidence of damage but an unknown technical issue in the extract of data was experienced 
with one device. Moreover, over half of the participants had problems with mobility and used 
a walker or were fully bedbound and this may have had an impact on the accuracy of 
detection of step counts.   
4. Discussion 
To our knowledge, this was the first attempt to assess the effect of PARO on sleep and motor 
activity for individuals living with dementia and chronic pain. An individual, non-facilitated 
interaction with PARO was found to have some effects in reducing daytime sleep and 
improving night-time sleep when compared with a usual care routine. However, no 
significant results were found for motor activity. These results suggest that PARO may have 
the potential to improve sleep in residents experiencing chronic pain and dementia.  
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Some studies have demonstrated the effect of interacting with robots on sleep 
patterns. For example, a robot at the RACF could provide the opportunity for residents to 
stimulate their day-time activity and thus help residents develop better daytime and night-
time sleeping patterns [25]. Results from interviews with residents with dementia indicated 
that interacting with PARO made people feel calm and this could help with their sleep [26]. 
Similarly, care staff reported that a robotic cat may bring feelings of calm and safety for 
residents and thus may be used as an alternative for sedative medication [27]. This may be 
explained by the fact that social robots may have similar benefits to live pets and their 
presence could provide a sense of safety and security, which could promote sleep [28]. 
However, two previous studies [16, 29] found no significant effect of PARO on the sleep of 
people with dementia.  
Several reasons regarding the participants and the intervention format may contribute 
to these inconclusive results. The trial population in this current study had a lower level of 
mobility due to chronic pain and a lower level of cognitive function at baseline than the 
population of larger published RCTs [16, 29]. The degree of cognitive impairment could 
impact the intervention efficacy of PARO on participants but the relationship between the 
severity of cognitive impairment and responses from using social robots remains unclear [13]. 
Another reason that results may have diverged from past trials is the frequency and duration 
of the intervention. A daily 30-minute intervention for five days a week was applied in this 
study, which is more frequent and longer than previous studies with only 15-minutes for three 
sessions per week [16] or 10-minute for two sessions per week [29]. There is still currently an 
absence of consensus on the appropriate intervention dose of PARO intervention for people 
with dementia which could impact on the intervention efficacy of PARO. The challenges of 
using social robots in clinical practice have been reported, including the high cost (US$6000) 
[30] and a lack of skills and confidence to the uptake of social robots in daily practice [31]. 
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Previous research on PARO was researcher-centered [30] and stakeholders including 
clinicians, families, policymakers and organizational leaders need to be engaged to identify 
strategies to enable the successful translation of robotic technology into practice.  
It is challenging to maintain the compliance of wearing the SenseWear armband for 
people with dementia for a prolonged period. A systematic review reported that the issue of 
repeated removal of actigraphy devices, in particular at night, often occurs in studies 
involving people with dementia [21]. Therefore, low compliance with wearing the devices 
results in a large source of data loss and creates interpretation issues. Researchers generally 
require at least 10 hours of wear time to ensure accurate estimates of motor activity [22]. 
However, it should be noted that this is based on younger participants who were cognitively 
healthy, and therefore, there was no wear time requirement in this study and this requirement 
may differ in older adults with dementia. Moreover, the armband was unable to detect the 
movement of arms and measure step counts when people are using a walker. Some 
researchers recommend attaching the device to the hip via an elastic belt to measure motor 
activity and improve compliance in people with dementia [32]. However, the attachment 
methods may depend on the design of the actigraphy or the study outcomes, as well as 
feasibility within the study population. It is therefore recommended to develop a protocol of 
using device-based sleep and activity monitoring tailored to people with dementia in terms of 
placement site, methods of attachment and the number of days of recording. Approaches are 
needed to improve compliance with protocols by avoiding the removal of the device and 
increase the sensitivity to detect sleep and motor activity of cognitively impaired subjects. 
This study has several limitations. First, this trial was conducted with a small sample of 
41 residents with dementia and chronic pain living in RACFs in Australia, and results may 
not be generalizable to people in other settings with different conditions. Moreover, future 
studies with a larger number of participants would allow for subgroup analysis to investigate 
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personal (e.g., impaired mobility), environmental (e.g., secure dementia care units) and 
organizational factors (e.g., exercise programs) relating to physical activity [33] and sleep [34] 
in people with dementia living in RACFs. Second, although the duration of wearing the 
actigraphy was comparable between the intervention and usual care groups with an average 
on-body time of 10 hours (out of 12 hours), results should be interpreted with caution as 
longer wear-time may produce different results. Third, only a 24-hour period was recorded at 
each time point and this may reduce the internal validity and reliability of the results 
considering the high levels of individual variations in daily physical activities. Evidence 
suggests at least three consecutive days of recordings are necessary to accurately estimate 
daily physical activity in older adults [35]. Despite the control of gender in the analysis, the 
imbalance of gender ratio between two groups may bring bias to results as studies suggest 
that females may respond and interact more positively to PARO compared to males [36]. 
Finally, although the blinding of participants and researchers were compromised in this 
study, this might not significantly affect objective outcomes. 
5. Conclusion 
PARO could potentially improve sleep for long-term care residents with dementia and 
chronic pain. Whether this type of intervention could be effective in motor activity requires 
further research. However, the small sample size may have limited the power and suggests 
the need for larger-scale trials. This study also highlights the challenges of using SenseWear 
armband to collect objective data with cognitively impaired residents and further 
development of such devices is needed. 
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♦ Lost to follow-up (n=0) 
♦ Discontinued usual care (n=0) 
♦ Refuse to wear the armband (n=2) 
 
♦ Lost to follow-up (n=1, deceased) 
♦ Discontinued PARO intervention (n=1, frailty) 
♦ Refuse to wear the armband (n=0) 
Assessed for eligibility (n=190) 
♦ Facility 1 (n=79) 
♦ Facility 2 (n=61) 
♦ Facility 3 (n=50) 
 
Excluded (n=147) 
♦ Not meeting inclusion criteria (n=119) 
♦ Declined to participate (n=23) 
♦ MMSE > 25 (n=4) 
♦ Admitted to hospital (n=1) 
 
Included for data analysis (n=21) 
Allocated to the intervention group:  
    PARO intervention with usual care (n=21) 
• 30 min/per day, Mon. ~Fri. 
• six weeks, 15h 
♦ Received PARO intervention (n=21) 
♦ Did not receive PARO intervention (n=0) 
♦ Refuse to wear the armband (n=0) 
 
Allocated to the control group: 
    Usual care only (n=22) 
• music, bingo, activities, etc. 
• six weeks 
♦ Received usual care (n=21) 
♦ Did not receive usual care (n=1, deceased) 
♦ Refuse to wear the armband (n=2) 
 
Included for data analysis (n=20) 
 
Allocation at baseline 
Analysis 
Follow-up at week 6 
Randomized (n=43) 
Enrolment 
Figure 1 CONSORT flow diagram 
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Table 1 Demographics and medical conditions of participants with SenseWear data 
Variables Control group 
(n = 20) 
Intervention group 
(n = 21) 
p value 
Age* 85.50±6.02 
  86.5 (72, 93) 
86.48±8.81 
90 (65, 97) 
0.234† 
Gender  
    Female 











    Alzheimer's disease 
    Vascular dementia  
     Frontal-temporal dementia 













     Secure dementia unit 











     Single room 










    Ambulatory 
    Assistive devices 
    Wheelchair 












Walking exercise, yes 10 (50.0%) 15 (71.4%) 0.160‡ 
Admission month* 33.2±29.32 
25 (3, 100) 
24.8±23.68 









Variables Control group 
(n = 20) 
Intervention group 
(n = 21) 
p value 






The intensity of pain 
    No pain 
    Mild 
    Moderate 










         1 (4.8%) 
0.486§ 
Nurse-estimated pain score* 
 
3.05±2.09 
3 (0, 8) 
3.24±2.49 
3 (0, 9) 
0.915† 
MQS score for medication* 14.54±8.59 
13.5 (2.2, 36.9) 
14.56±7.86 
12.4 (3.8, 33.7) 
0.896† 
Note. * values presented as Mean ± SD/median (range), Bold values are statistically significant (p < .05). 
Abbreviations: SD, Standard Deviation; MMSE, Mini-Mental State Examination; BMI, Body Mass Index; 
 MQS, Medication quantification scale-III. 
†value was calculated with Mann-Whitney U test 
‡ value was calculated by Chi-square test 
§value was calculated by Fisher’s exact test 
||value was calculated with independent t-test
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Table 2 Mean scores and standard deviations for SenseWear outcomes at four-time points (n=41) 
 PARO group (n=21)  Usual care group (n=20) 
Baseline Week 1 Week 6 After  Baseline Week 1 Week 6 After 
SenseWear, daytime  
Time on body (hrs.) 9.46 (1.99) 11.15 (1.87) 10.49 (2.73) 10.62 (2.24)  9.47 (1.86) 10.23 (3.08) 10.46 (2.58) 9.89 (3.59) 
Skin temperature (°C) 33.27 (1.10) 33.23 (0.93) 32.55 (2.41) 33.12 (1.27)  33.30 (0.76) 32.72 (1.37) 32.96 (1.49) 33.24 (1.17) 
Distance (kilometers) 0.03 (0.09) 0.05 (0.23) 0.05 (0.200 0.03 (0.13)  0.03 (0.10) 0.04 (0.11) 0.03 (0.08) 0.04 (0.10) 
















Lying down (hrs.) 2.49 (3.37) 2.96 (3.73) 2.60 (3.02) 2.26 (2.37)  0.68 (1.05)  1.64 (2.79) 2.38 (3.36) 1.59 (2.77) 
Average MET 1.22 (0.11) 1.21 (0.11) 1.19 (0.21) 1.15 (0.10)  1.25 (0.16) 1.24 (0.18) 1.17 (0.14) 1.20 (0.19) 
Physical activity (hrs.) 1.07 (0.97) 1.17 (1.28) 0.84 (1.29) 0.71 (0.93)  1.45 (1.25) 1.51 (1.42) 0.95 (0.99) 1.12 (1.36) 
















Awake (hrs.) 7.45 (3.35) 8.75 (3.79) 8.59 (3.45) 9.00 (3.26)  9.01 (2.20) 9.29 (3.27) 8.66 (3.28) 8.84 (4.09) 
Total sleep (hrs.) 2.01 (2.93) 2.40 (3.48) 1.90 (2.80) 1.61 (2.18)  0.47 (0.90) 0.95 (1.72) 1.80 (2.78) 1.05 (2.55) 
  Light sleep (hrs.) 1.62 (2.43) 1.77 (2.61) 1.30 (1.80) 1.34 (1.82)  0.33 (0.55) 0.66 (1.02) 1.38 (2.03) 0.73 (1.74) 
  Deep sleep (hrs.) 0.24 (0.53) 0.33 (0.71) 0.37 (0.75) 0.16 (0.22)  0.10 (0.25) 0.19 (0.56) 0.28 (0.47) 0.22 (0.56) 
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 PARO group (n=21)  Usual care group (n=20) 
Baseline Week 1 Week 6 After  Baseline Week 1 Week 6 After 
  Very deep sleep (hrs.) 0.15 (0.31) 0.33 (0.71) 0.23 (0.50) 0.11 (0.28)  0.04 (0.15) 0.19 (0.56) 014 (0.46) 0.11 (0.31) 
SenseWear, night-time  
Time on body (hrs.) 9.33 (4.25) 10.85 (2.73) 9.66 (4.24) 9.89 (3.98)  9.80 (4.14) 10.31 (3.91) 10.61 (3.65) 10.08 (4.05) 
Skin temperature 
(°C) 
33.33 (1.27) 32.35 (7.44) 31.64 (7.52) 33.66 (1.21)  33.41 (1.16) 31.85 (7.57) 31.62 (7.56) 33.42 (1.29) 
Distance (kilometers) 0.00 (0.02) 0.00 (0.00) 0.00 (0.14) 0.00 (0.00)  0.03 (0.12) 0.01 (0.03) 0.00 (0.02) 0.01 (0.03) 
Step counter (n) 25.67  
(55.89) 
41.71 (66.66) 97.10 
(336.36) 








Lying down (hrs.) 7.06 (4.42) 8.85 (3.12) 7.35 (4.24) 6.72 (4.12)  5.53 (4.12) 6.41 (3.61) 6.31 (4.00) 6.34 (3.49) 
Average MET 1.15 (0.31) 1.00 (0.26) 1.05 (0.35) 1.13 (0.32)  1.11 (0.16) 1.01 (0.28) 1.03 (0.30) 1.16 (0.47) 
Physical activity (hrs) 0.26 (0.43) 0.35 (0.54) 0.24 (0.32) 0.27 (0.36)  0.57 (0.83) 0.48 (0.54) 0.64 (0.92) 0.55 (0.87) 
















Awake (hrs.) 3.78 (3.17) 3.74 (2.53) 3.92 (3.07) 4.93 (3.53)  5.83 (3.82)† 5.75 (3.34) 6.08 (3.92) 5.52 (3.26) 
Total sleep (hrs.) 5.55 (4.31) 7.11 (3.30) 5.74 (4.10) 4.95 (4.13)  3.97 (3.73) 4.56 (3.24) 4.53 (3.63) 4.56 (3.22) 
  Light sleep (hrs.) 3.64 (2.72) 5.72 (2.58) 4.24 (2.95) 3.29 (2.80)  2.87 (2.61) 3.14 (1.8 9) 3.08 (2.32) 2.91 (1.84) 
  Deep sleep (hrs.) 1.05 (1.25) 1.04 (1.08) 0.81 (1.28) 1.05 (1.23)  0.56 (0.79) 0.89 (1.26) 1.01 (1.79) 1.03 (1.39) 
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 PARO group (n=21)  Usual care group (n=20) 
Baseline Week 1 Week 6 After  Baseline Week 1 Week 6 After 
  Very deep sleep (hrs.) 0.87 (1.37) 0.35 (0.55) 0.69 (0.96) 0.62 (1.05)  0.54 (0.82) 0.53 (0.73) 0.44 (0.56) 0.63 (0.97) 
Abbreviations: hrs, hours; mins, minutes; EE, energy expenditure; MET, metabolic equivalent; physical activity was calculated as the average time (mins) spent in activities 
with an estimated EE ≥ 1.5 metabolic equivalents (METs), which is at least light physical activity.  
Bolded values indicate statistically significant results at week 0 for the level of p<0.05. 






Table 3 The effectiveness of PARO intervention on SenseWear outcomes# (n=41) 
Outcomes PARO intervention effect at week 6 Short term effect at week 1 Sustained effect after the intervention 
 Mean difference  
(95% CI) in change  
p  
 
ES Mean difference  
(95% CI) in change  
   p  ES Mean difference  
(95% CI) in change  
p   
SenseWear, daytime  
Skin temperature (°C) 0.02 (-0.79, 0.83) 0.957   0.54 (-0.13, 1.22) 0.167  -0.10 (-0.78, 0.59) 0.781  
Distance (kilometers) 0.02 (-0.06, 0.10) 0.283  0.01 (-0.10, 0.12) 0.522  -0.01 (-0.06, 0.05) 0.705  
Step counter (n) 42.83  
(-43.87, 129.53) 
0.277   69.25  
(-16.87, 155.37) 
0.177  24.01  
(-30.21, 80.23) 
0.435  
Lying down (hrs) -1.49 (-3.12, 0.15) 0.139  -0.49 (-1.89, 0.90) 0.968  -1.14 (-2.74, 0.46) 0.491  
Average MET -0.02 (-0.10, 0.06) 0.298  -0.02 (-0.71, 0.68) 0.647  -0.11 (-0.32, 0.09) 0.397  
Physical activity (hrs) 0.26 (-0.35, 0.86) 0.403  0.01 (-0.79, 0.82,) 0.973  -0.14 (-0.67, 0.39) 0.603  
EE (kcal) 317.88  
(-349.43, 985.18) 
0.235  394.15  
(-353.81, 1142.12) 
0.286  252.92  
(-527.63, 11033.47) 
0.477  
Awake (hrs) 1.91 (0.09, 3.73) 0.042 0.655 1.01 (-1.08, 3.11) 0.676  1.72 (-0.63, 4.07) 0.548  
Total sleep (hrs) -1.35 (-2.65, -0.05) 0.040 0.664 -0.09 (-1.13, 0.95) 0.819  -1.15 (-2.28, 0.03) 0.651  
   Light sleep (hrs) -1.27 (-2.36, -0.19) 0.023 0.746 -0.18 (-0.96, 0.61) 0.873  -0.68 (-1.88, 0.52) 0.779  
  Deep sleep (hrs) 0.06 (-0.41, 0.29) 0.281  0.00 (-0.43, 0.43) 0.497  -0.20 (-0.50, 0.10) 0.861  
  Very deep sleep (hrs) -0.02 (-0.26, 0.21) 0.712  0.09 (-0.15, 0.33) 0.819  -0.16 (-0.42, 0.09) 0.734  
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Outcomes PARO intervention effect at week 6 Short term effect at week 1 Sustained effect after the intervention 
 Mean difference  
(95% CI) in change  
p  
 
ES Mean difference  
(95% CI) in change  
   p  ES Mean difference  
(95% CI) in change  
p   
SenseWear, nighttime 
Skin temperature (°C) 0.09 (-4.48, 4.66,) 0.584  0.56 (-3.98, 5.11) 0.361  0.31 (-0.40, 1.02) 0.544  
Distance (kilometers) 0.17 (-0.13, 0.46) 0.598  0.02 (-0.03, 0.07) 0.603  0.02 (-0.04, 0.07) 0.336  
Step counter (n) 10.7.78 
(-63.74, 279.30) 
0.565  65.50 
(-873.97, 139.73) 
0.754  56.94 
(-30.14, 144.02) 
0.785  
Lying down (hrs) -0.49 (-3.43, 2.45) 0.738   0.91 (-1.94, 3.76) 0.522  -1.15 (-3.60, 1.31) 0.915  
Average MET -0.01 (-0.19, 0.16) 0.938  -0.05 (-0.25, 0.14) 0.835  -0.07 (-0.28, 0.14) 0.476  
Physical activity (hrs) 0.14 (-0.23, 0.51) 0.452  0.23 (-0.19, 0.64) 0.280   0.11 (-0.28, 0.50) 0.568  
EE (kcal) -320.03  
(-1134.10, 494.03) 
0.346  26.77  
(-767.30, 820.84) 
0.936  -197.43  
(-915.64, 520.79) 
0.702  
Awake (hrs) -0.98 (-3.19, 1.22) 0.298  -1.20 (-2.99, 0.60) 0.146  0.27 (-1.60, 2.13) 0.799  
Total sleep (hrs) -0.37 (-3.04, 2.30) 0.781  0.97 (-1.67, 3.62) 0.462  -0.41 ( -3.04, 2.22) 0.747  
  Light sleep (hrs) 0.38 (-1.76, 2.52) 0.720  1.81 (0.22, 3.84) 0.030 0.57 -0.39 (-2.09, 1.32) 0.811  
  Deep sleep (hrs) -0.8 (-1.61, 0.25) 0.162  -0.33 (-1.03, 0.37) 0.344  -0.47 (-1.11, 0.18) 0.206  
  Very deep sleep (hrs) -0.07 (-0.88, 0.73) 0.464  -0.51 (-1.24, 0.23) 0.753  -0.34 (-2.32, 0.26) 0.770  
Abbreviations: hrs, hours; mins, minutes; EE, energy expenditure; MET, metabolic equivalent; ES, the effect size was calculated by Cohen’s d; Bolded values indicate 
statistically significant results at the level of p<0.05. 
Short term effect means the change on Monday at week 1, sustained effect means the change on Saturday at week 6. 
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 # Values were calculated with the generalized estimating equation model adjusted for gender and imbalanced baseline value. Change scores reflected the difference between 
the given assessment time-point and the values recorded at week 0 baseline.  
Mean difference between groups = Mean difference in the intervention group - Mean difference in the control group, positive scores in favour of PARO group for daytime 
skin temperature, distance, step counter, physical activity, average MET, energy expenditure, awake and night-time lying down and sleep; negative scores in favour of PARO 
group for daytime lying down, sleep and nighttime skin temperature, distance, step counter, physical activity, average MET, energy expenditure, and awake. 
 
 
